Sujay Kango

Mr. Kango is an experienced executive with more than 25 years of experience in the pharmaceutical and biotechnology industries. He has been instrumental in successfully transforming earlier-stage organizations into later-stage development and commercial global biotech companies. Prior to Tmunity, Mr. Kango served as Chief Commercial Officer at Acceleron Pharma, where he played a key role in the company’s $11.5 billion acquisition by Merck.

His other previous roles included Vice President of Global Commercial Development for oncology at AbbVie, Executive Vice President and Chief Commercial Officer at Infinity Pharmaceuticals, and several leadership positions at Onyx, Merck, Ortho-Biotech, and Schering-Plough. Mr. Kango currently serves as a member on the Boards of Directors of MEI Pharma and Infinity Pharmaceuticals.